Trial Profile
A retrospective study investigating efficacy of Bevacizumab therapy in pediatric patients with relapsed or refractory low-grade glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 26 Feb 2016 New trial record